Featured Research

from universities, journals, and other organizations

Clinical trial tests new treatment for rare cancer

Date:
October 15, 2013
Source:
University of Michigan Health System
Summary:
Adrenal cancer researchers are seeing the results of their laboratory studies translate to a clinical trial to test a potential new therapy in patients.

One of the most challenging cancers to treat is also one of the rarest, which only adds to the challenge of finding potential new therapies.

Now adrenal cancer researchers at the University of Michigan Comprehensive Cancer Center are seeing the results of their laboratory studies translate to a clinical trial to test a potential new therapy in patients.

Researchers Tom Kerppola, Ph.D., and Gary Hammer, M.D., Ph.D., collaborated to test a new compound, ATR-101, in cell lines and mice. Their studies found that ATR-101 selectively killed the adrenal and adrenal cancer cells with very little effect on other cells in the body.

Less than a year after these findings, ATR-101 is now in a phase I clinical trial at the University of Michigan Comprehensive Cancer Center and the University of Texas MD Anderson Cancer Center, testing the safety of the compound in people with advanced adrenocortical carcinoma. The trial, which is the first time this compound is being tested in humans, will enroll 21 participants. The drug is a pill taken orally.

The ATR-101 study is offered by Atterocor Inc., a Michigan-based company that was co-founded by Hammer to develop new adrenal cancer therapies. Hammer serves as a consultant to Atterocor and is chairman of the scientific advisory board. He is not involved in the clinical trial at U-M.

"Many adrenal cancer patients are desperate for new therapeutic options, and ATR-101 is one of the few compounds in the world directed at this ultra-rare disease," says Gary Hammer, M.D., Ph.D., Millie Schembechler Professor of Adrenal Cancer at the U-M Comprehensive Cancer Center.

Hammer's endowed professorship is the result of years of fundraising by legendary U-M football coach Bo Schembechler, whose wife Millie died of adrenal cancer. This funding directed specifically at adrenal cancer has allowed U-M to create a level of expertise -- both research and patient care -- in this extremely rare disease.

Adrenal cancer is one of the most deadly types of cancer, with few treatment options available. Standard therapy, which causes severe side effects, has been the same for more than 40 years. About 500 people will be diagnosed with adrenal cancer this year in the United States and most will die within five years. The disease is often diagnosed at a late stage and surgery is rarely an option.


Story Source:

The above story is based on materials provided by University of Michigan Health System. Note: Materials may be edited for content and length.


Cite This Page:

University of Michigan Health System. "Clinical trial tests new treatment for rare cancer." ScienceDaily. ScienceDaily, 15 October 2013. <www.sciencedaily.com/releases/2013/10/131015103645.htm>.
University of Michigan Health System. (2013, October 15). Clinical trial tests new treatment for rare cancer. ScienceDaily. Retrieved August 19, 2014 from www.sciencedaily.com/releases/2013/10/131015103645.htm
University of Michigan Health System. "Clinical trial tests new treatment for rare cancer." ScienceDaily. www.sciencedaily.com/releases/2013/10/131015103645.htm (accessed August 19, 2014).

Share This




More Health & Medicine News

Tuesday, August 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola-Hit Sierra Leone's Freetown a City on Edge

Ebola-Hit Sierra Leone's Freetown a City on Edge

AFP (Aug. 19, 2014) Residents of Sierra Leone's capital voice their fears as the Ebola virus sweeps through west Africa. Duration: 00:56 Video provided by AFP
Powered by NewsLook.com
101-Year-Old Working Man Has All The Advice You Need

101-Year-Old Working Man Has All The Advice You Need

Newsy (Aug. 19, 2014) Herman Goldman has worked at the same lighting store for almost 75 years. Find out his secrets to a happy, productive life. Video provided by Newsy
Powered by NewsLook.com
Researcher Testing on-Field Concussion Scanners

Researcher Testing on-Field Concussion Scanners

AP (Aug. 19, 2014) Four Texas high school football programs are trying out an experimental system designed to diagnose concussions on the field. The technology is in response to growing concern over head trauma in America's most watched sport. (Aug. 19) Video provided by AP
Powered by NewsLook.com
American Ebola Patient Apparently Improving, Outbreak Is Not

American Ebola Patient Apparently Improving, Outbreak Is Not

Newsy (Aug. 19, 2014) Nancy Writebol, an American missionary who contracted Ebola, is apparently getting better, according to her husband. The outbreak, however, is not. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins